Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medtronic Inc (MDT)

Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 112,558,200
  • Shares Outstanding, K 1,283,885
  • Annual Sales, $ 33,537 M
  • Annual Income, $ 4,662 M
  • EBIT $ 7,957 M
  • EBITDA $ 10,818 M
  • 60-Month Beta 0.71
  • Price/Sales 3.36
  • Price/Cash Flow 11.34
  • Price/Book 2.29

Options Overview Details

View History
  • Implied Volatility 24.97% (+1.34%)
  • Historical Volatility 20.50%
  • IV Percentile 81%
  • IV Rank 39.36%
  • IV High 41.66% on 04/08/25
  • IV Low 14.14% on 12/09/25
  • Expected Move (DTE 6) 1.88 (2.17%)
  • Put/Call Vol Ratio 0.34
  • Today's Volume 2,076
  • Volume Avg (30-Day) 9,409
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 129,418
  • Open Int (30-Day) 149,939
  • Expected Range 84.83 to 88.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/26
See More
  • Average Estimate 1.65
  • Number of Estimates 11
  • High Estimate 1.69
  • Low Estimate 1.54
  • Prior Year 1.62
  • Growth Rate Est. (year over year) +1.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
85.78 +1.56%
on 03/20/26
98.77 -11.80%
on 03/02/26
-10.54 (-10.79%)
since 02/27/26
3-Month
85.78 +1.56%
on 03/20/26
105.50 -17.42%
on 02/04/26
-9.40 (-9.74%)
since 12/26/25
52-Week
79.55 +9.52%
on 04/09/25
106.33 -18.07%
on 11/26/25
-1.86 (-2.09%)
since 03/27/25

Most Recent Stories

More News
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures

GALWAY, Ireland , March 27, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth...

MDT : 87.12 (+0.18%)
5 Spin-Off Stocks That Could Reward Patient Investors in 2026

Spin-offs are a way for CEOs to unleash growth and unlock shareholder value; this is a look at five spin-offs that are getting bullish attention from analysts.

LMT : 622.07 (-0.84%)
NOC : 689.26 (-0.39%)
KDP : 26.38 (+1.31%)
HON : 225.83 (+0.29%)
RTX : 191.55 (-0.67%)
KBR : 37.60 (+0.19%)
FDX : 346.74 (-0.80%)
MDT : 87.12 (+0.18%)
ISRG : 456.29 (-2.62%)
Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area

MDT : 87.12 (+0.18%)
Is Insulet Stock Underperforming the Dow?

Insulet has underperformed the Dow recently, yet analysts remain highly optimistic about the stock’s prospects.

PODD : 211.52 (-3.02%)
$DOWI : 45,591.00 (-0.80%)
MDT : 87.12 (+0.18%)
How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks?

Zimmer Biomet Holdings stock has lagged other medical device stocks over the past year, while analysts are neutral about its prospects.

ZBH : 88.50 (-0.73%)
IHI : 53.59 (-1.29%)
MDT : 87.12 (+0.18%)
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update

$106.5 million cash position as of December 31, 2025 to be further enhanced by $35 million expected from Medtronic and Ligand in Q2 2026 from previously announced transactions, as well as Haemonetics’...

MDT : 87.12 (+0.18%)
OBIO : 4.43 (-1.34%)
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care

Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'

MDT : 87.12 (+0.18%)
Is Edwards Lifesciences Stock Outperforming the S&P 500?

Edwards Lifesciences has outperformed the S&P 500 recently, and analysts remain moderately optimistic about the stock’s prospects.

EW : 79.29 (-3.42%)
$SPX : 6,415.24 (-0.96%)
MDT : 87.12 (+0.18%)
MiniMed to begin trading on Nasdaq Global Select Market

GALWAY, Ireland , March 6, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that MiniMed Group, Inc. (Nasdaq: MMED) will begin trading today on...

MMED : 14.81 (-3.01%)
MDT : 87.12 (+0.18%)
MiniMed announces pricing of initial public offering

GALWAY, Ireland and NORTHRIDGE, Calif. , March 5, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced the pricing of its...

MDT : 87.12 (+0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience...

See More

Key Turning Points

3rd Resistance Point 90.68
2nd Resistance Point 89.93
1st Resistance Point 88.80
Last Price 87.12
1st Support Level 86.92
2nd Support Level 86.17
3rd Support Level 85.04

See More

52-Week High 106.33
Fibonacci 61.8% 96.10
Fibonacci 50% 92.94
Fibonacci 38.2% 89.78
Last Price 87.12
52-Week Low 79.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.